AMP-activated protein kinase activator A-769662 is an inhibitor of the Na+-K+-ATPase

American Journal of Physiology - Cell Physiology

Volumn 297, Issue 6, 2009, Pages

  Benziane, Boubacar ^a   Björnholm, Marie ^a   Lantier, Louise ^b,c   Viollet, Benoit ^b,c   Zierath, Juleen R ^a   Chibalin, Alexander V ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUT COCHIN   (France)

^c INSERM   (France)

Author keywords

Ouabain; Skeletal muscle cells

Indexed keywords

6,7 DIHYDRO 4 HYDROXY 3 (2' HYDROXY 1,1' BIPHENYL 4 YL) 6 OXOTHIENO[2,3 B]PYRIDINE 5 CARBONITRILE; ACETYL COENZYME A CARBOXYLASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; OUABAIN; (6 (4 (2 PIPERIDIN 1 YLETHOXY)PHENYL)) 3 PYRIDIN 4 YLPYRAZOLO(1,5 A)PYRIMIDINE; (6-(4-(2-PIPERIDIN-1-YLETHOXY)PHENYL))-3-PYRIDIN-4-YLPYRAZOLO(1,5-A)PYRIMIDINE; ENZYME INHIBITOR; INSULIN; ISOENZYME; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE; PYRONE DERIVATIVE; SMALL INTERFERING RNA; THIOPHENE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MUSCLE CELL; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; ANIMAL; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME; TRANSPORT AT THE CELLULAR LEVEL;

RATTUS; STROPHANTHUS GRATUS;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; INSULIN; ISOENZYMES; MICE; MICE, KNOCKOUT; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; OUABAIN; PHOSPHORYLATION; PYRAZOLES; PYRIMIDINES; PYRONES; RATS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE; THIOPHENES; TIME FACTORS;

EID: 73449087698     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00010.2009     Document Type: Article

References (55)

1. +-ATPase by phosphorylation of the alpha-subunit in human skeletal muscle cells. J Biol Chem 279: 25211-25218, 2004.
2. Almaca J, Kongsuphol P, Hieke B, Ousingsawat J, Viollet B, Schreiber R, Amaral MD, Kunzelmann K. AMPK controls epithelial Na(+) channels through Nedd4-2 and causes an epithelial phenotype when mutated. Pflügers Arch 458: 713-721, 2009.
3. + channel through functional regulation of the ubiquitin ligase Nedd4-2. J Biol Chem 281: 26159-26169, 2006.
4. Bilan PJ, Mitsumoto Y, Maher F, Simpson IA, Klip A. Detection of the GLUT3 facilitative glucose transporter in rat L6 muscle cells: regulation by cellular differentiation, insulin and insulin-like growth factor-I. Biochem Biophys Res Commun 186: 1129-1137, 1992.
5. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol Renal Physiol 275: F633-F650, 1998.
6. Boldyrev AA, Fedosova NU. Comparison of the kinetic properties of membrane-bound and solubilized Na,K-ATPase. Biochem Int 22: 903-911, 1990.
7. Carattino MD, Edinger RS, Grieser HJ, Wise R, Neumann D, Schlattner U, Johnson JP, Kleyman TR, Hallows KR. Epithelial sodium channel inhibition by AMP-activated protein kinase in oocytes and polarized renal epithelial cells. J Biol Chem 280: 17608-17616, 2005.
8. Chen S, Murphy J, Toth R, Campbell DG, Morrice NA, MacKintosh C. Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem J 409: 449-459, 2008.
9. +-ATPase. J Physiol 518: 37-46, 1999.
10. +-adenosine triphosphatase alpha-subunits in rat skeletal muscle. Endocrinology 142: 3474-3482, 2001.
11. +-ATPase is initiated by phosphorylation of Ser-18 in the rat alpha subunit and is responsible for the decreased activity in epithelial cells. J Biol Chem 274: 1920-1927, 1999.
12. +-ATPase endocytosis. J Biol Chem 273: 8814-8819, 1998.
13. Cool B, Zinker B, Chiou W, Kifle L, Cao N, Perham M, Dickinson R, Adler A, Gagne G, Iyengar R, Zhao G, Marsh K, Kym P, Jung P, Camp HS, Frevert E. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 3: 403-416, 2006.
14. Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-Aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMPactivated protein kinase in intact cells? Eur J Biochem 229: 558-565, 1995.
15. Dada LA, Chandel NS, Ridge KM, Pedemonte C, Bertorello AM, Sznajder JI. Hypoxia-induced endocytosis of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta. J Clin Invest 111: 1057-1064, 2003.
16. + channels by AMP-activated protein kinase. Adv Exp Med Biol 648: 57-63, 2009.
17. El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275: 223-228, 2000.
18. - co-transporter NKCC2 by AMP-activated protein kinase (AMPK). Biochem J 405: 85-93, 2007.
19. Fryer LGD, Parbu-Patel A, Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277: 25226-25232, 2002.
20. Goransson O, McBride A, Hawley SA, Ross FA, Shpiro N, Foretz M, Viollet B, Hardie DG, Sakamoto K. Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J Biol Chem 282: 32549-32560, 2007.
21. Guigas B, Taleux N, Foretz M, Detaille D, Andreelli F, Viollet B, Hue L. AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. Biochem J 404: 499-507, 2007.
22. +-ATPase accumulation in epididymal clear cells. Am J Physiol Cell Physiol 296: C672-C681, 2009.
23. Hallows KR, Raghuram V, Kemp BE, Witters LA, Foskett JK. Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J Clin Invest 105: 1711-1721, 2000.
24. Hardie DG. AMP-activated protein kinase: a key system mediating metabolic responses to exercise. Med Sci Sports Exerc 36: 28-34, 2004.
25. Hardie DG. The AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144: 5179-5183, 2003.
26. Hardie DG, Sakamoto K. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda) 21: 48-60, 2006.
27. +-ATPase: enzyme sources, preparative problems, and preparation from mammalian kidney. Methods Enzymol 156: 29-43, 1988.
28. Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, Walter M, Gupta A, Adams JJ, Katsis F, van Denderen B, Jennings IG, Iseli T, Michell BJ, Witters LA. AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans 31: 162-168, 2003.
29. - secretion by AMPK in vivo. Pflügers Arch 457: 1071-1078, 2009.
30. Konrad D, Rudich A, Bilan PJ, Patel N, Richardson C, Witters LA, Klip A. Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells. Diabetologia 48: 954-966, 2005.
31. Kotova O, Al-Khalili L, Talia S, Hooke C, Fedorova OV, Bagrov AY, Chibalin AV. Cardiotonic steroids stimulate glycogen synthesis in human skeletal muscle cells via a Src- and ERK1/2-dependent mechanism. J Biol Chem 281: 20085-20094, 2006.
32. LeBrasseur NK, Kelly M, Tsao TS, Farmer SR, Saha AK, Ruderman NB, Tomas E. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am J Physiol Endocrinol Metab 291: E175-E181, 2006.
33. Lefebvre DL, Bai Y, Shahmolky N, Sharma M, Poon R, Drucker DJ, Rosen CF. Identification and characterization of a novel sucrose-nonfermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK. Biochem J 355: 297-305, 2001.
34. +-ATPase. J Biol Chem 269: 19659-19662, 1994.
35. Liu J, Liang M, Liu L, Malhotra D, Xie Z, Shapiro JI. Ouabain-induced endocytosis of the plasmalemmal Na//K-ATPase in LLC-PK1 cells requires caveolin-1. Kidney Int 67: 1844-1854, 2005.
36. Liu J, Shapiro JI. Regulation of sodium pump endocytosis by cardiotonic steroids: molecular mechanisms and physiological implications. Pathophysiology 14: 171-181, 2007.
37. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116: 1776-1783, 2006.
38. + exchanger in rat hearts - possible contribution to cardioprotection. Pflügers Arch 453: 147-156, 2006.
39. Moreno D, Knecht E, Viollet B, Sanz P. A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism. FEBS Lett 582: 2650-2654, 2008.
40. Mounier R, Lantier L, Leclerc J, Sotiropoulos A, Pende M, Daegelen D, Sakamoto K, Foretz M, Viollet B. Important role for AMPKalpha1 in limiting skeletal muscle cell hypertrophy. FASEB J 23: 2264-2273, 2009.
41. Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348: 607-614, 2000.
42. +-ATPase activity in cultured rat skeletal muscle cells. J Biol Chem 272: 23653-23658, 1997.
43. Rosen ED, Spiegelman BM. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276: 37731-37734, 2001.
44. Sakamoto K, Goransson O, Hardie DG, Alessi DR. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR. Am J Physiol Endocrinol Metab 287: E310-E317, 2004.
45. Sanders MJ, Ali ZS, Hegarty BD, Heath R, Snowden MA, Carling D. Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family. J Biol Chem 282: 32539-32548, 2007.
46. + exchanger 1 in isolated rat ventricular cardiomyocytes. Endocrinology 149: 1490-1498, 2008.
47. Soltoff SP, Hedden L. Regulation of ERK1/2 by ouabain and Na-K-ATPase-dependent energy utilization and AMPK activation in parotid acinar cells. Am J Physiol Cell Physiol 295: C590-C599, 2008.
48. + channels. J Cell Physiol 210: 224-236, 2007.
49. 1-subunit in HEK-293 cells. Am J Physiol Cell Physiol 281: C1797-C1803, 2001.
50. 2-induced alveolar epithelial dysfunction in rats and human cells by promoting Na,K-ATPase endocytosis. J Clin Invest 118: 752-762, 2008.
51. Wolf DH, Hilt W. The proteasome: a proteolytic nanomachine of cell regulation and waste disposal. Biochim Biophys Acta 1695: 19-31, 2004.
52. + transport across H441 lung cells. J Physiol 566: 781-792, 2005.
53. + transport processes across human lung epithelial cells. Br J Pharmacol 151: 1204-1215, 2007.
54. +]. Am J Physiol Cell Physiol 294: C126-C135, 2008.
55. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174, 2001.